nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—CYP2D6—breast cancer	0.341	1	CbGaD
Remoxipride—SIGMAR1—Raloxifene—breast cancer	0.277	0.469	CbGbCtD
Remoxipride—SIGMAR1—Tamoxifen—breast cancer	0.183	0.31	CbGbCtD
Remoxipride—CYP2D6—Idarubicin—breast cancer	0.0542	0.0917	CbGbCtD
Remoxipride—CYP2D6—Vinorelbine—breast cancer	0.0265	0.0448	CbGbCtD
Remoxipride—CYP2D6—Tamoxifen—breast cancer	0.0239	0.0404	CbGbCtD
Remoxipride—CYP2D6—Vinblastine—breast cancer	0.0163	0.0276	CbGbCtD
Remoxipride—CYP2D6—Doxorubicin—breast cancer	0.01	0.017	CbGbCtD
Remoxipride—Sulpiride—CA9—breast cancer	0.00262	0.62	CrCbGaD
Remoxipride—Sulpiride—BCHE—breast cancer	0.0016	0.38	CrCbGaD
Remoxipride—HTR2A—Signaling Pathways—H2AFX—breast cancer	8.92e-06	0.000141	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—breast cancer	8.91e-06	0.000141	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FASN—breast cancer	8.91e-06	0.000141	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—BCHE—breast cancer	8.87e-06	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—E2F1—breast cancer	8.85e-06	0.00014	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PIK3CA—breast cancer	8.85e-06	0.00014	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—breast cancer	8.83e-06	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CB—breast cancer	8.81e-06	0.000139	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC5A5—breast cancer	8.76e-06	0.000138	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—KRAS—breast cancer	8.74e-06	0.000138	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SPP1—breast cancer	8.65e-06	0.000137	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK3—breast cancer	8.64e-06	0.000137	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—breast cancer	8.61e-06	0.000136	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB3—breast cancer	8.55e-06	0.000135	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGFR2—breast cancer	8.54e-06	0.000135	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SPP1—breast cancer	8.51e-06	0.000134	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—BRAF—breast cancer	8.48e-06	0.000134	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—breast cancer	8.47e-06	0.000134	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A1—breast cancer	8.46e-06	0.000134	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NQO1—breast cancer	8.46e-06	0.000134	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NOS3—breast cancer	8.43e-06	0.000133	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB3—breast cancer	8.41e-06	0.000133	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGFR2—breast cancer	8.4e-06	0.000133	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—breast cancer	8.26e-06	0.000131	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT2—breast cancer	8.26e-06	0.00013	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP3A4—breast cancer	8.25e-06	0.00013	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—breast cancer	8.23e-06	0.00013	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—breast cancer	8.22e-06	0.00013	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TERT—breast cancer	8.2e-06	0.000129	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1B1—breast cancer	8.11e-06	0.000128	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—breast cancer	8.09e-06	0.000128	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TERT—breast cancer	8.06e-06	0.000127	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PIK3CA—breast cancer	8.03e-06	0.000127	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MDM2—breast cancer	8e-06	0.000126	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RAF1—breast cancer	7.97e-06	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HSP90AA1—breast cancer	7.96e-06	0.000126	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGFR1—breast cancer	7.96e-06	0.000126	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RELA—breast cancer	7.94e-06	0.000125	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CD—breast cancer	7.93e-06	0.000125	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ERBB2—breast cancer	7.89e-06	0.000125	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PIK3CA—breast cancer	7.86e-06	0.000124	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—breast cancer	7.85e-06	0.000124	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HIF1A—breast cancer	7.84e-06	0.000124	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGFR1—breast cancer	7.83e-06	0.000124	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MTOR—breast cancer	7.78e-06	0.000123	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CB—breast cancer	7.78e-06	0.000123	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—KRAS—breast cancer	7.77e-06	0.000123	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NCOA1—breast cancer	7.74e-06	0.000122	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HIF1A—breast cancer	7.71e-06	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—breast cancer	7.65e-06	0.000121	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—STK11—breast cancer	7.63e-06	0.000121	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP19A1—breast cancer	7.63e-06	0.000121	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CAV1—breast cancer	7.58e-06	0.00012	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—breast cancer	7.53e-06	0.000119	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KDR—breast cancer	7.5e-06	0.000118	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOS3—breast cancer	7.49e-06	0.000118	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—breast cancer	7.48e-06	0.000118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CAV1—breast cancer	7.46e-06	0.000118	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HRAS—breast cancer	7.43e-06	0.000117	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KDR—breast cancer	7.38e-06	0.000116	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1B—breast cancer	7.31e-06	0.000115	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ESR1—breast cancer	7.3e-06	0.000115	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—breast cancer	7.23e-06	0.000114	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FN1—breast cancer	7.22e-06	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ESR1—breast cancer	7.19e-06	0.000114	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—breast cancer	7.16e-06	0.000113	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—breast cancer	7.15e-06	0.000113	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3CA—breast cancer	7.14e-06	0.000113	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NFKBIA—breast cancer	7.13e-06	0.000113	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—breast cancer	7.11e-06	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MDM2—breast cancer	7.11e-06	0.000112	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FN1—breast cancer	7.1e-06	0.000112	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—COMT—breast cancer	7.09e-06	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RAF1—breast cancer	7.08e-06	0.000112	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOTCH1—breast cancer	7.06e-06	0.000112	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTP1—breast cancer	7.06e-06	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RELA—breast cancer	7.05e-06	0.000111	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NFKBIA—breast cancer	7.02e-06	0.000111	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ERBB2—breast cancer	7.01e-06	0.000111	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCND1—breast cancer	6.97e-06	0.00011	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMOX1—breast cancer	6.96e-06	0.00011	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—JUN—breast cancer	6.95e-06	0.00011	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOTCH1—breast cancer	6.95e-06	0.00011	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ITPR1—breast cancer	6.95e-06	0.00011	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MTOR—breast cancer	6.91e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CB—breast cancer	6.91e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CG—breast cancer	6.9e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APC—breast cancer	6.9e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KIT—breast cancer	6.9e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CTNNB1—breast cancer	6.9e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGF—breast cancer	6.83e-06	0.000108	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KIT—breast cancer	6.79e-06	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APC—breast cancer	6.79e-06	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CG—breast cancer	6.79e-06	0.000107	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—breast cancer	6.77e-06	0.000107	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1A—breast cancer	6.74e-06	0.000106	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTEN—breast cancer	6.73e-06	0.000106	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGF—breast cancer	6.72e-06	0.000106	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCB1—breast cancer	6.68e-06	0.000106	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—breast cancer	6.64e-06	0.000105	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK3—breast cancer	6.61e-06	0.000104	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HRAS—breast cancer	6.6e-06	0.000104	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK8—breast cancer	6.58e-06	0.000104	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TYMS—breast cancer	6.56e-06	0.000104	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—breast cancer	6.56e-06	0.000104	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK3—breast cancer	6.51e-06	0.000103	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—BRAF—breast cancer	6.49e-06	0.000103	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1B—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NCOR1—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G4A—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—breast cancer	6.42e-06	0.000101	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—BRAF—breast cancer	6.39e-06	0.000101	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—breast cancer	6.36e-06	0.0001	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—breast cancer	6.35e-06	0.0001	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—breast cancer	6.32e-06	9.99e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—breast cancer	6.32e-06	9.98e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT2—breast cancer	6.32e-06	9.98e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—breast cancer	6.29e-06	9.94e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SRC—breast cancer	6.24e-06	9.85e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—breast cancer	6.22e-06	9.83e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT2—breast cancer	6.22e-06	9.82e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX1—breast cancer	6.21e-06	9.81e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCND1—breast cancer	6.19e-06	9.78e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—breast cancer	6.19e-06	9.78e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—JUN—breast cancer	6.18e-06	9.76e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A1—breast cancer	6.15e-06	9.71e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CTNNB1—breast cancer	6.13e-06	9.68e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ERCC2—breast cancer	6.1e-06	9.63e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—breast cancer	6.08e-06	9.6e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CD—breast cancer	6.07e-06	9.59e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—breast cancer	6.02e-06	9.5e-05	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	6.01e-06	9.5e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—breast cancer	6.01e-06	9.49e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—breast cancer	6e-06	9.48e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1A—breast cancer	5.99e-06	9.46e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTEN—breast cancer	5.97e-06	9.44e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CD—breast cancer	5.97e-06	9.43e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—KRAS—breast cancer	5.94e-06	9.39e-05	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	5.92e-06	9.34e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—breast cancer	5.91e-06	9.33e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—KRAS—breast cancer	5.85e-06	9.24e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK8—breast cancer	5.84e-06	9.23e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—breast cancer	5.83e-06	9.21e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK3—breast cancer	5.75e-06	9.08e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—breast cancer	5.73e-06	9.06e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOS3—breast cancer	5.73e-06	9.05e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOS3—breast cancer	5.64e-06	8.91e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MYC—breast cancer	5.59e-06	8.83e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—breast cancer	5.58e-06	8.81e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SRC—breast cancer	5.54e-06	8.75e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—breast cancer	5.47e-06	8.64e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CA—breast cancer	5.46e-06	8.62e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MDM2—breast cancer	5.44e-06	8.59e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAF1—breast cancer	5.42e-06	8.56e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—breast cancer	5.4e-06	8.52e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RELA—breast cancer	5.4e-06	8.52e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	5.37e-06	8.49e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB2—breast cancer	5.36e-06	8.47e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MDM2—breast cancer	5.35e-06	8.45e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—breast cancer	5.34e-06	8.44e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAF1—breast cancer	5.33e-06	8.42e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RELA—breast cancer	5.31e-06	8.39e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CB—breast cancer	5.29e-06	8.36e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MTOR—breast cancer	5.29e-06	8.36e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CAV1—breast cancer	5.29e-06	8.35e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB2—breast cancer	5.28e-06	8.33e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CB—breast cancer	5.21e-06	8.22e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MTOR—breast cancer	5.21e-06	8.22e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KRAS—breast cancer	5.17e-06	8.16e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK3—breast cancer	5.11e-06	8.06e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—breast cancer	5.08e-06	8.03e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HRAS—breast cancer	5.05e-06	7.98e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—breast cancer	5e-06	7.9e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HRAS—breast cancer	4.97e-06	7.85e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1B—breast cancer	4.97e-06	7.84e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MYC—breast cancer	4.97e-06	7.84e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—breast cancer	4.95e-06	7.82e-05	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—breast cancer	4.91e-06	7.76e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1B—breast cancer	4.89e-06	7.72e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—breast cancer	4.87e-06	7.69e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—breast cancer	4.86e-06	7.68e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—breast cancer	4.86e-06	7.67e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—breast cancer	4.83e-06	7.64e-05	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—breast cancer	4.83e-06	7.63e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CG—breast cancer	4.82e-06	7.61e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—breast cancer	4.79e-06	7.56e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—breast cancer	4.78e-06	7.55e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—breast cancer	4.76e-06	7.51e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CA—breast cancer	4.75e-06	7.5e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCND1—breast cancer	4.74e-06	7.48e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JUN—breast cancer	4.73e-06	7.47e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CTNNB1—breast cancer	4.69e-06	7.41e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCND1—breast cancer	4.66e-06	7.36e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JUN—breast cancer	4.65e-06	7.35e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CTNNB1—breast cancer	4.62e-06	7.29e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—breast cancer	4.6e-06	7.26e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TP53—breast cancer	4.59e-06	7.25e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KRAS—breast cancer	4.59e-06	7.25e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1A—breast cancer	4.58e-06	7.24e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTEN—breast cancer	4.57e-06	7.22e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—breast cancer	4.53e-06	7.15e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1A—breast cancer	4.51e-06	7.12e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTEN—breast cancer	4.5e-06	7.11e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK8—breast cancer	4.47e-06	7.06e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—breast cancer	4.46e-06	7.05e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK8—breast cancer	4.4e-06	6.95e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HRAS—breast cancer	4.39e-06	6.93e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—breast cancer	4.39e-06	6.93e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SRC—breast cancer	4.24e-06	6.7e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CD—breast cancer	4.23e-06	6.69e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CA—breast cancer	4.22e-06	6.66e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—breast cancer	4.2e-06	6.64e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—breast cancer	4.18e-06	6.6e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SRC—breast cancer	4.17e-06	6.59e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—breast cancer	4.13e-06	6.52e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—breast cancer	4.09e-06	6.46e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TP53—breast cancer	4.08e-06	6.44e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—breast cancer	4.06e-06	6.42e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—breast cancer	4.02e-06	6.36e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NOS3—breast cancer	4e-06	6.32e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK3—breast cancer	3.91e-06	6.17e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HRAS—breast cancer	3.9e-06	6.16e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—breast cancer	3.88e-06	6.12e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK3—breast cancer	3.84e-06	6.07e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MYC—breast cancer	3.8e-06	6e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—breast cancer	3.79e-06	5.99e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MYC—breast cancer	3.74e-06	5.91e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—breast cancer	3.73e-06	5.9e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—breast cancer	3.73e-06	5.89e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—breast cancer	3.72e-06	5.87e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CB—breast cancer	3.69e-06	5.83e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—breast cancer	3.66e-06	5.78e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—breast cancer	3.66e-06	5.78e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KRAS—breast cancer	3.51e-06	5.55e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KRAS—breast cancer	3.45e-06	5.46e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—breast cancer	3.44e-06	5.44e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CA—breast cancer	3.23e-06	5.09e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTEN—breast cancer	3.19e-06	5.04e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CA—breast cancer	3.17e-06	5.01e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TP53—breast cancer	3.12e-06	4.93e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TP53—breast cancer	3.07e-06	4.85e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HRAS—breast cancer	2.98e-06	4.71e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HRAS—breast cancer	2.94e-06	4.64e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—breast cancer	2.86e-06	4.51e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—breast cancer	2.81e-06	4.44e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—breast cancer	2.63e-06	4.16e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—breast cancer	2.59e-06	4.1e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CA—breast cancer	2.25e-06	3.55e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—breast cancer	1.84e-06	2.9e-05	CbGpPWpGaD
